IL93490A - Pharmaceutical preparations containing ranitidine - Google Patents

Pharmaceutical preparations containing ranitidine

Info

Publication number
IL93490A
IL93490A IL9349090A IL9349090A IL93490A IL 93490 A IL93490 A IL 93490A IL 9349090 A IL9349090 A IL 9349090A IL 9349090 A IL9349090 A IL 9349090A IL 93490 A IL93490 A IL 93490A
Authority
IL
Israel
Prior art keywords
filling
ranitidine
pharmaceutical composition
mixture
fatty acids
Prior art date
Application number
IL9349090A
Other languages
English (en)
Hebrew (he)
Other versions
IL93490A0 (en
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of IL93490A0 publication Critical patent/IL93490A0/xx
Publication of IL93490A publication Critical patent/IL93490A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL9349090A 1989-02-23 1990-02-22 Pharmaceutical preparations containing ranitidine IL93490A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL93490A0 IL93490A0 (en) 1990-11-29
IL93490A true IL93490A (en) 1994-07-31

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9349090A IL93490A (en) 1989-02-23 1990-02-22 Pharmaceutical preparations containing ranitidine

Country Status (26)

Country Link
US (1) US5028432A (hu)
JP (1) JP2856817B2 (hu)
KR (1) KR940006271B1 (hu)
AT (1) AT401727B (hu)
AU (1) AU629303B2 (hu)
BE (1) BE1003123A3 (hu)
CA (1) CA2010692C (hu)
CH (1) CH680567A5 (hu)
CY (1) CY1734A (hu)
DE (1) DE4005650C2 (hu)
DK (1) DK170209B1 (hu)
FR (1) FR2643263B1 (hu)
GB (2) GB8904182D0 (hu)
HK (1) HK89493A (hu)
HU (1) HU211930A9 (hu)
IE (1) IE63179B1 (hu)
IL (1) IL93490A (hu)
IT (1) IT1240768B (hu)
LU (1) LU87681A1 (hu)
NL (1) NL193267C (hu)
NZ (1) NZ232642A (hu)
PH (1) PH26972A (hu)
SA (1) SA90100287B1 (hu)
SE (1) SE512412C2 (hu)
ZA (1) ZA901348B (hu)
ZW (1) ZW1790A1 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004893A1 (en) * 1990-09-13 1992-04-02 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
ES2107685T3 (es) * 1992-10-16 1997-12-01 Glaxo Group Ltd Composiciones de ranitidina que enmascaran su sabor.
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
ES2294197T3 (es) * 2001-12-21 2008-04-01 Supernus Pharmaceuticals, Inc. Formulacion de capsula oral con estabilidad fisica aumentada.
EP1592760A4 (en) * 2003-01-31 2009-08-12 Smithkline Beecham Corp AS FIXED DISPERSIONS, COMPOSITIONS
KR101152470B1 (ko) 2003-08-13 2012-06-01 바이오콘 리미티드 치료제용 마이크로-입자 지방산 염 고형 투약 제형
US9579269B2 (en) 2010-06-23 2017-02-28 Colgate-Palmolive Company Therapeutic oral composition
US9320690B2 (en) 2010-12-20 2016-04-26 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
MY163496A (en) 2010-12-20 2017-09-15 Colgate Palmolive Co Non-aqueous oral care composition containing dental occlusion actives
SG190860A1 (en) 2010-12-20 2013-07-31 Colgate Palmolive Co Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier
EP3534880B1 (en) * 2016-11-01 2022-05-18 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な1α−ヒドロキシビタミンD類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
GB2084580B (en) * 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
EP0077529B1 (de) * 1981-10-16 1985-07-17 Sanol Schwarz GmbH Arzneimittelformulierung
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
SE8302689L (sv) * 1982-05-14 1983-11-15 Richter Gedeon Vegyeszet Farmaceutiska kompositioner innehallande flera aktiva bestandsdelar
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
DE3490358T1 (de) * 1983-08-01 1985-10-31 R.P. Scherer Corp., Troy, Mich. Retard-Verfahren und -erzeugnis
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions

Also Published As

Publication number Publication date
CY1734A (en) 1994-05-06
HK89493A (en) 1993-09-03
NL193267B (nl) 1999-01-04
KR900012612A (ko) 1990-09-01
PH26972A (en) 1992-12-28
NL193267C (nl) 1999-05-06
GB8904182D0 (en) 1989-04-05
ZW1790A1 (en) 1991-10-16
FR2643263B1 (fr) 1994-09-16
SE9000625L (sv) 1990-08-24
GB2229094A (en) 1990-09-19
NL9000428A (nl) 1990-09-17
SA90100287B1 (ar) 1999-08-15
DE4005650C2 (de) 1999-03-25
JPH03200728A (ja) 1991-09-02
LU87681A1 (fr) 1991-10-08
BE1003123A3 (fr) 1991-12-03
NZ232642A (en) 1992-07-28
AU629303B2 (en) 1992-10-01
DK48090A (da) 1990-08-24
GB2229094B (en) 1993-01-06
GB9004016D0 (en) 1990-04-18
SE512412C2 (sv) 2000-03-13
DE4005650A1 (de) 1990-09-06
IL93490A0 (en) 1990-11-29
FR2643263A1 (fr) 1990-08-24
US5028432A (en) 1991-07-02
SE9000625D0 (sv) 1990-02-22
IT9047659A1 (it) 1991-08-22
ATA42190A (de) 1996-04-15
KR940006271B1 (ko) 1994-07-14
IE900651L (en) 1990-08-23
DK48090D0 (da) 1990-02-22
AT401727B (de) 1996-11-25
CA2010692C (en) 1995-12-12
IT9047659A0 (it) 1990-02-22
CA2010692A1 (en) 1990-08-23
IE63179B1 (en) 1995-03-22
JP2856817B2 (ja) 1999-02-10
AU5007390A (en) 1990-08-30
CH680567A5 (hu) 1992-09-30
IT1240768B (it) 1993-12-17
ZA901348B (en) 1991-03-27
HU211930A9 (en) 1996-01-29
DK170209B1 (da) 1995-06-19

Similar Documents

Publication Publication Date Title
CA2010692C (en) Gelatin capsules containing ranitidine
KR910000655B1 (ko) 신규 형태의 연질캡슐 제조방법
PT2279729T (pt) Preparações de libertação controlada
WO1995016438A1 (en) Biphasic capsule formulation
JPH0830006B2 (ja) ビタミン類、食事療法用補助食品等を含むソフトゲル用エタノ−ル充填製剤
EP0173293B1 (en) Hot melt antihistamine formulations
JPH0816051B2 (ja) 徐放性坐剤
JPS6024767B2 (ja) 腸溶性硬カプセル剤
AU1168099A (en) Formulations comprising dissolved paroxetine
ES2344898T3 (es) Sistema de administracion oral que comprende una espuma biliquida.
US20020032220A1 (en) Formulations comprising dissolved paroxetine
EP0326103B1 (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
EP0431659B1 (en) Pharmaceutical compositions of tebufelone
JPH10330250A (ja) メナテトレノン油性製剤
JPH07549B2 (ja) 軟カプセル充填用組成物
JPS61200909A (ja) 経口投与持続性カプセル剤
JPS59106418A (ja) ニフエジピン製剤
JPH0420891B2 (hu)
CA2310407A1 (en) Formulations comprising dissolved paroxetine
CZ20001876A3 (cs) Prostředky obsahující rozpuštěný paroxetin

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired